255 related articles for article (PubMed ID: 28913767)
1. Management of Atypical Renal Cell Carcinomas.
Liaw BC; Mehrazin R; Baker C; Sfakianos JP; Tsao CK
Curr Treat Options Oncol; 2017 Sep; 18(10):61. PubMed ID: 28913767
[TBL] [Abstract][Full Text] [Related]
2. Non-clear cell renal cell carcinomas: biological insights and therapeutic challenges and opportunities.
Malouf GG; Joseph RW; Shah AY; Tannir NM
Clin Adv Hematol Oncol; 2017 May; 15(5):409-418. PubMed ID: 28591094
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
4. Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.
Wilson NR; Acikgoz Y; Hasanov E
Int J Cancer; 2024 Mar; 154(6):947-961. PubMed ID: 37823185
[TBL] [Abstract][Full Text] [Related]
5. Contemporary management of advanced renal cell carcinoma.
Khanna A; Crane A; Yerram N; Sun D; Ericson K; Lundy SD; Abouassaly R
Clin Adv Hematol Oncol; 2018 Jun; 16(6):438-446. PubMed ID: 30067615
[TBL] [Abstract][Full Text] [Related]
6. Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials.
Maughan BL; Sirohi D
Curr Treat Options Oncol; 2023 Sep; 24(9):1199-1212. PubMed ID: 37407886
[TBL] [Abstract][Full Text] [Related]
7. Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature.
John A; Spain L; Hamid AA
Curr Oncol; 2023 Jan; 30(1):923-937. PubMed ID: 36661719
[TBL] [Abstract][Full Text] [Related]
8. Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data.
Barthélémy P; Rioux-Leclercq N; Thibault C; Saldana C; Borchiellini D; Chevreau C; Desmoulins I; Gobert A; Hilgers W; Khalil A; Lemoine N; Schlürmann-Constans F; Négrier S
Cancer Treat Rev; 2021 Jun; 97():102191. PubMed ID: 34015728
[TBL] [Abstract][Full Text] [Related]
9. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
[TBL] [Abstract][Full Text] [Related]
10. Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives.
Pagani F; Colecchia M; Sepe P; Apollonio G; Claps M; Verzoni E; de Braud F; Procopio G
Cancer Treat Rev; 2019 Sep; 79():101891. PubMed ID: 31491662
[TBL] [Abstract][Full Text] [Related]
11. Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma.
Christensen BR; Hajja YM; Koshkin V; Barata PC
Curr Treat Options Oncol; 2021 Jan; 22(2):15. PubMed ID: 33438115
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
[TBL] [Abstract][Full Text] [Related]
13. Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
Goebell PJ; Ivanyi P; Bedke J; Bergmann L; Berthold D; Boegemann M; Busch J; Doehn C; Krege S; Retz M; Amsberg GV; Grimm MO; Gruenwald V
Future Oncol; 2020 Oct; 16(29):2307-2328. PubMed ID: 32964728
[TBL] [Abstract][Full Text] [Related]
14. Advanced Non-Clear Cell Kidney Cancer: In Search of Rational Treatment Approaches.
Ornstein MC; Hutson TE
Cancer J; 2020; 26(5):441-447. PubMed ID: 32947312
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive review of chromophobe renal cell carcinoma.
Garje R; Elhag D; Yasin HA; Acharya L; Vaena D; Dahmoush L
Crit Rev Oncol Hematol; 2021 Apr; 160():103287. PubMed ID: 33753250
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Presentation and Treatment Outcomes of Non-clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia.
Naher S; Padinharakam S; Balakrishnar B; Chua W; Descallar J; Adams D; de Souza P; Harrison M; Lim S
Clin Genitourin Cancer; 2019 Jun; 17(3):e565-e569. PubMed ID: 30935815
[TBL] [Abstract][Full Text] [Related]
17. Integrating Immunotherapy Into the Management of Renal Cell Carcinoma.
Zibelman M; Plimack ER
J Natl Compr Canc Netw; 2017 Jun; 15(6):841-847. PubMed ID: 28596263
[TBL] [Abstract][Full Text] [Related]
18. Evolving Treatment Paradigms in Non-clear Cell Kidney Cancer.
Vaishampayan U
Curr Treat Options Oncol; 2018 Jan; 19(1):5. PubMed ID: 29368112
[TBL] [Abstract][Full Text] [Related]
19. Metastatic non-clear cell renal cell carcinoma: current therapeutic options.
Schrader AJ; Olbert PJ; Hegele A; Varga Z; Hofmann R
BJU Int; 2008 Jun; 101(11):1343-5. PubMed ID: 18241246
[TBL] [Abstract][Full Text] [Related]
20. Systemic Therapy for Non-Clear Cell Renal Cell Carcinoma.
Zhang T; Gong J; Maia MC; Pal SK
Am Soc Clin Oncol Educ Book; 2017; 37():337-342. PubMed ID: 28561708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
